| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |